This release summarises the survival of adults diagnosed with cancer in England between 2016 and 2020 and followed to 2021, and children diagnosed with cancer in England between 2002 and 2020 and followed to 2021. Adult cancer survival estimates are presented by age, deprivation, gender, stage at diagnosis, and geography.

One-year and five-year net survival for adults (15-99) in England diagnosed with one of 29 common cancers, by age and sex.

Age-standardised rate of mortality from oral cancer (ICD-10 codes C00-C14) in persons of all ages and sexes per 100,000 population.RationaleOver the last decade in the UK (between 2003-2005 and 2012-2014), oral cancer mortality rates have increased by 20% for males and 19% for females1Five year survival rates are 56%. Most oral cancers are triggered by tobacco and alcohol, which together account for 75% of cases2. Cigarette smoking is associated with an increased risk of the more common forms of oral cancer. The risk among cigarette smokers is estimated to be 10 times that for non-smokers. More intense use of tobacco increases the risk, while ceasing to smoke for 10 years or more reduces it to almost the same as that of non-smokers3. Oral cancer mortality rates can be used in conjunction with registration data to inform service planning as well as comparing survival rates across areas of England to assess the impact of public health prevention policies such as smoking cessation.References:(1) Cancer Research Campaign. Cancer Statistics: Oral – UK. London: CRC, 2000.(2) Blot WJ, McLaughlin JK, Winn DM et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-7. (3) La Vecchia C, Tavani A, Franceschi S et al. Epidemiology and prevention of oral cancer. Oral Oncology 1997; 33: 302-12.Definition of numeratorAll cancer mortality for lip, oral cavity and pharynx (ICD-10 C00-C14) in the respective calendar years aggregated into quinary age bands (0-4, 5-9,…, 85-89, 90+). This does not include secondary cancers or recurrences. Data are reported according to the calendar year in which the cancer was diagnosed.Counts of deaths for years up to and including 2019 have been adjusted where needed to take account of the MUSE ICD-10 coding change introduced in 2020. Detailed guidance on the MUSE implementation is available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/causeofdeathcodinginmortalitystatisticssoftwarechanges/january2020Counts of deaths for years up to and including 2013 have been double adjusted by applying comparability ratios from both the IRIS coding change and the MUSE coding change where needed to take account of both the MUSE ICD-10 coding change and the IRIS ICD-10 coding change introduced in 2014. The detailed guidance on the IRIS implementation is available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/impactoftheimplementationofirissoftwareforicd10causeofdeathcodingonmortalitystatisticsenglandandwales/2014-08-08Counts of deaths for years up to and including 2010 have been triple adjusted by applying comparability ratios from the 2011 coding change, the IRIS coding change and the MUSE coding change where needed to take account of the MUSE ICD-10 coding change, the IRIS ICD-10 coding change and the ICD-10 coding change introduced in 2011. The detailed guidance on the 2011 implementation is available at https://webarchive.nationalarchives.gov.uk/ukgwa/20160108084125/http://www.ons.gov.uk/ons/guide-method/classifications/international-standard-classifications/icd-10-for-mortality/comparability-ratios/index.htmlDefinition of denominatorPopulation-years (aggregated populations for the three years) for people of all ages, aggregated into quinary age bands (0-4, 5-9, …, 85-89, 90+)

In the years 2016 to 2020, over ** percent of patients diagnosed with melanoma of the skin in England aged between 15 and 44 years of age would survive for at least one year, while patients this age had a five-year survival rate of nearly ** percent. The survival rates for melanoma of the skin did generally fall if the patient was older when diagnosed.

Statistics on observed and relative survival of cancer patients (25 cancers plus for all cancers combined) in Scotland, at 1, 3, 5 and 10 years, by age and sex. Source agency: ISD Scotland (part of NHS National Services Scotland) Designation: National Statistics Language: English Alternative title: Cancer Survival

This publication reports on newly diagnosed cancers registered in England during 2022. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registration estimates are provided for: • Incidence of cancer using groupings that incorporate both the location and type of cancer by combinations of gender, age, deprivation, and stage at diagnosis (where appropriate) for England, former Government office regions, Cancer alliances and Integrated care boards • Incidence and mortality (using ICD-10 3-digit codes) by gender and age group for England, former Government office regions, Cancer alliances and Integrated care boards This publication will report on 2022 cancer registrations only, trends will not be reported as the required re-stated populations for 2012 to 2020 are not expected to be published by the Office of National Statistics (ONS) until Winter 2024.

This bulletin presents the latest one- and five-year age-standardised net survival estimates for adults (aged 15-99 years) diagnosed in England with one of the 21 most common cancers. These cancers comprise over 90% of all newly diagnosed cancers. Source agency: Office for National Statistics Designation: National Statistics Language: English Alternative title: Cancer survival rates

This presents the latest one- and five-year age-standardised relative survival rates for cancers of the bladder, breast (in women), cervix, colon, lung, oesophagus, prostate and stomach with data for the government office regions (GOR) and strategic health authorities (SHA). Source agency: Office for National Statistics Designation: National Statistics Language: English Alternative title: Cancer survival in England by Health Authority

In 2019, approximately ** men and ** women per 100,000 population died from lung cancer in England. The North East of England had the highest mortality from lung cancer for both genders with a rate of approximately ** men and ** women per 100,000 population.

Smoothed life tables for use in cancer survival, by sex, index of multiple deprivation, age and region of England.

Survival estimates for children (aged 0 to 14 years) diagnosed with cancer in England from 2001 to 2017.

1-year cancer survival by Clinical Commissioning Group for all cancers combined, three cancers combined, breast, colorectal and lung. 1-, 5- and 10-year index of cancer survival estimates are also available by Sustainability and Transformation Partnerships and Cancer Alliances.

Legacy unique identifier: P00624

This dataset includes information regarding Cancer survival in England where adults aged 15 to 99 were diagnosed between 2013 and 2017 and followed up to 2018. When the data for this report were extracted for analysis on 11 August 2019, cancer registrations in 2017 were believed to be at least 98% complete, and the vital status for each patient at 31 December 2017 was known for at least 99% of cancers registered between 2013 and 2017.

Legacy unique identifier: P00225

In the period 2013 to 2017, over ** percent of those aged between 15 and 44 years who were diagnosed with liver cancer in England survived for at least *** year after being diagnosed, while ** percent survived for five years. Over the period provided, the older age groups have a lower survival rate than the younger age groups.

Survival estimates for adults diagnosed with cancer, by stage, for years 2012, 2013, 2014 and 2015, England

In the period 2013 to 2017, every person who was diagnosed with stage one melanoma skin cancer in England survived for at least *** year after being diagnosed, while over **** percent survived for five years. This highlights the importance of detecting cancers early. In individuals diagnosed with stage four skin cancer, ** percent survived for at least *** year.